MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall
Rhea-AI Summary
MIMEDX Group, Inc. (Nasdaq: MDXG) announced its participation in the Symposium on Advanced Wound Care (SAWC) Fall meeting from October 2-5 in Las Vegas. The company will showcase its allograft portfolio and latest scientific and clinical evidence. Key events include:
1. A sponsored lunch symposium on the evolving wound care landscape.
2. A hands-on skills lab focusing on managing lower extremity wounds.
3. Seven accepted poster presentations covering clinical and scientific research.
MIMEDX will also have representatives at booth 511 to discuss product news and clinical information. Dr. John R. Harper, MIMEDX Chief Scientific Officer, emphasized the company's leadership in expanding understanding of placental tissue's characteristics and potential clinical benefits, particularly in inflammation and epithelialization.
Positive
- MIMEDX is presenting seven accepted clinical and scientific posters at SAWC Fall, demonstrating strong research output
- The company is sponsoring a lunch symposium and hands-on skills lab, showcasing its industry leadership
- MIMEDX continues to expand its portfolio of clinical and scientific research, reinforcing its market position
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, MDXG declined 1.69%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Company to Sponsor Lunch Symposium and Hands-On Skills Lab
Featuring Seven Accepted Posters, Further Expanding Its Best-In-Class Portfolio of Clinical and Scientific Research
MARIETTA, Ga., Oct. 01, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced its schedule for the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place October 2-5 in Las Vegas, NV. SAWC Fall is the largest gathering of advanced wound care industry and healthcare professionals and serves as an educational forum to connect with this global community.
“Our research and clinical teams have continued to extend our leadership in expanding the understanding of placental tissue’s unique characteristics and potential clinical benefits,” said Dr. John R. Harper, Ph.D., MIMEDX Chief Scientific Officer. “At SAWC this year, we are proud to once again highlight new research on our product portfolio in two areas that are key to the wound healing cascade, namely inflammation and epithelialization. We continue striving to lead the field in scientific publications and Level I clinical data. In addition, we are excited to connect with attendees with valuable sessions, including a hands-on skills lab that will provide a deep dive into innovative treatment techniques.”
In addition to the events highlighted below, MIMEDX sales representatives and medical science liaisons will be onsite during exhibit hall hours at booth 511 to discuss the latest product news and clinical information.
Sponsored Lunch Symposium
Wound Care Evolution: Patients Change, Practices Change, Payors Change: Providers Adapt
Date/Time: Thursday, October 3 / 11:40 a.m. – 1:10 p.m. PDT
Faculty: Ehab Sorial, MD, FACS; Naz Wahab, MD, FAAFP, FAPWCA; Dorothy Kurtz Phelan, DPM, D.BFAS, FACFAS; Allyn Forsyth, PhD
Description: This symposium will cover the rapidly changing landscape of wound care, particularly around the use and reimbursement of skin substitutes. As patient populations shift and treatment methodologies evolve, healthcare professionals must stay ahead of the curve to provide optimal care.
Hands-On Skills Lab (CME-Eligible)
Overcoming Challenges in Assessing and Managing Lower Extremity Wounds: Hands-On Workshop
Date/Time: Thursday, October 3 / 1:20 p.m. – 4:40 p.m. PDT
Moderator: Pamela Scarborough, PT, DPT, CWS, FAAWC
MIMEDX Presenter: Randall Spencer
Description: This hands-on workshop will explore innovative treatment techniques for the most common lower extremity wounds. Attendees will engage in experiential learning through product demonstrations of debridement technologies, compression therapy, negative pressure wound therapy, skin substitutes, and more.
Accepted Poster Presentations
The Company is pleased to announce that seven clinical and scientific posters have been accepted and will be on display in the poster hall.
Clinical Research
- Chronic Pressure Injuries: More than Taking the Pressure off with Lyophilized Human Amnion/Chorion Membrane
- Dehydrated Human Amnion Chorion Membrane for Reconstruction of Cutaneous Defects Following Mohs Surgery: A Propensity Score-Matched Comparative Cost-Effectiveness Analysis
- Survey of Patients with Hard-to-Heal Wounds
- The Impacts of Medicaid Status on Venous Leg Ulcer Outcomes
- Pyoderma Gangrenosum: A Light at the End of the Tunnel for an Orphan Disease: Dehydrated Human Amnion/Chorion Membrane
Scientific Research
- Lyophilized Human Amnionic Membrane Modulates the Macrophage Response During Wound Healing
- Tri-Layer Amniotic Membrane Allografts Promotes Re-Epithelialization In Vitro via cJUN Mediated Mechanism
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
FAQ
What events is MIMEDX participating in at SAWC Fall 2024?
What are the key research areas MIMEDX is focusing on for wound healing?
How many posters has MIMEDX had accepted for presentation at SAWC Fall 2024?
When and where is the SAWC Fall meeting taking place for MDXG?
